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Recalcitrant microbial infections demand new
therapeutic options. Here we present an approach
that exploits two prongs of the host immune cell
antimicrobial response: the oxidative burst and the
compartmentalization of copper (Cu) within phagoly-
sosomes. The prochelator QBP is a nontoxic pro-
tected form of 8-hydroxyquinoline (8HQ) in which
a pinanediol boronic ester blocks metal ion coordi-
nation by 8HQ. QBP is deprotected via reactive
oxygen species produced by activated macro-
phages, creating 8HQ and eliciting Cu-dependent
killing of the fungal pathogen Cryptococcus neofor-
mans in vitro and in mouse pulmonary infection.
8HQ ionophoric activity increases intracellular Cu,
overwhelming the Cu-resistance mechanisms of
C. neoformans to elicit fungal killing. The Cu-depen-
dent antimicrobial activity of 8HQ against a spectrum
of microbial pathogens suggests that this strategy
may have broad utility. The conditional activation of
Cu ionophores by innate immune cells intensifies
the hostile antimicrobial environment and represents
a promising approach to combat infectious disease.
INTRODUCTION
The need for new therapeutics to treat infectious disease is
widely recognized, but the scarcity of candidates in the drug
pipeline is alarming (Butts and Krysan, 2012). Opportunistic
fungal infections in particular are difficult to treat, as fungi are
ubiquitously found in the environment, are biochemically similar
to mammalian cells, and have limited classes of drugs available
(Day et al., 2013). New strategies and molecules with innovative
mechanisms of action to increase efficacy against their patho-
genic targets must be developed.
The transition metal copper (Cu) is essential for most forms of
life but can also be toxic, a duality that provides apromising tactic
for antimicrobial therapy development. Metallic Cu, Cu salts, and
Cu compounds have long been used to control bacterial, fungal,
and algal growth in agricultural and health care settings (BorkowChemistry & Biology 21, 97and Gabbay, 2005; Grass et al., 2011). However, pathogenic
microbes ultimately infect their host, and it is becoming apparent
thatmammalian hosts useCu to fight infections (Hodgkinson and
Petris, 2012; Samanovic et al., 2012). At the macroscopic level,
serum Cu levels increase in response to infection, and Cu-defi-
cient individuals are highly susceptible to infections (Milanino
and Buchner, 2006; Percival, 1998). At the cellular level, an
emerging model of Cu mobilization within macrophages during
infection is now coming into focus (Achard et al., 2012; Hodgkin-
son and Petris, 2012; Wagner et al., 2005; White et al., 2009).
One of themany roles of macrophages is to ingest and destroy
pathogens in specialized phagosomal compartments. Upon
macrophage activation, these compartments present a hostile
environment that includes an oxidative burst of hydrogen
peroxide and nitric oxide, along with lytic enzymes and acidic
pH (Flannagan et al., 2009). In addition, macrophages activated
with lipopolysaccharide (LPS) or interferon-gamma (IFN-g) in-
crease expression of the cell-surface Cu importer Ctr1 while
concurrently increasing levels of the Cu exporter ATP7A, which
partially localizes to phagosomes (White et al., 2009). The con-
centration of Cu in Mycobacteria-containing phagolysosomes
can reach hundreds of micromolar (Wagner et al., 2005). This
paradigm of compartmentalizing phagosomal Cu in response
to infection directly contrasts the concurrent movement of bio-
logically important metals, iron (Fe) and zinc (Zn), which are
actively expelled to starve pathogens of these essential metals
(Hood and Skaar, 2012).
Increasingly, the importance of Cu resistance pathways in
pathogenic bacteria and fungi is being recognized (Achard
et al., 2012; Ding et al., 2013; Gonza´lez-Guerrero et al., 2010).
Although the mechanism by which macrophage-associated Cu
elicits microbial toxicity are unclear, bacterial pathogens counter
Cu stress by inducing the expression of genes encoding multi-
Cu oxidases and Cu export machinery (Achard et al., 2010; Fu
et al., 2013; Solioz et al., 2010; Ward et al., 2010; White et al.,
2009). Fungi also adapt to elevated Cu during infection; for
example, Cryptococcus neoformans induces the expression of
genes encoding metallothioneins (MTs), cysteine-rich metal
binding proteins, to handle elevated host Cu in the lung (Ding
et al., 2013). These advances in Cu biology expose unexplored
opportunities to develop antimicrobial agents that accentuates
host Cu.
We hypothesized that small molecules can be designed as
novel antimicrobial agents that operate by manipulating Cu at7–987, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 977
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that they selectively mobilize endogenous Cu during infection,
avoid disrupting host metal status, exhibit Cu-based pathogen
killing, and evade the Cu-resistance mechanisms of the path-
ogen. Here, we report a compound based on 8-hydroxyquinoline
(8HQ), a metal-binding scaffold with known antimicrobial activity
(Anderson and Swaby, 1951). Although the mechanism of action
of 8HQ is multifaceted, its ability to form lipophilic, neutral com-
plexes with Zn(II) and Cu(II) that translocate these metal ions
across cell membranes independent of metal pumps and trans-
porters has been well documented (Li et al., 2010; Tardito et al.,
2011; Zhai et al., 2010). In addition to antimicrobial activity, com-
pounds in this family have also shown metal-dependent activity
against cancer and neurodegenerative diseases (Adlard et al.,
2008; Tardiff et al., 2012; Tardito et al., 2011; Zhai et al., 2010).
However, the metal-dependent toxicity extends to healthy
mammalian cells as well. Intraperitoneal administration of 8HQ
and its derivatives as Cu chelates results in toxicity that is gener-
ally far worse than the compounds alone (Bernstein et al., 1963;
Leanderson and Tagesson, 1996; Oliveri et al., 2012; Tardito
et al., 2012). Surface administration of 8HQ has been deemed
safe at low concentrations, but the data are insufficient to sup-
port safety at higher concentrations or for systemic administra-
tion (Andersen, 2006).
To mitigate off-target effects, we take advantage of QBP, a
prochelator form of 8HQ that is inactive and unable to bind Cu
unless its boronic ester masking group is removed by reacting
with hydrogen peroxide to release 8HQ (Figure 1A) (Dickens
and Franz, 2010). The oxidative burst generated by activated
macrophages is sufficient to mediate conversion of nontoxic
QBP to 8HQ, which subsequently elicits Cu-dependent cytotox-
icity. We use the opportunistic fungal pathogenC. neoformans to
show that 8HQ exerts its fungicidal effects by increasing cell-
associated Cu to overwhelm the Cu detoxification capacity of
C. neoformans. This work establishes prochelators as a class
of antimicrobial compounds that synergize with the host’s
response to infection and thereby disrupt the efficacy of micro-
bial Cu detoxification.RESULTS
QBP Converts to 8HQ in the Presence of Activated
RAW Macrophages
We hypothesized that the oxidative conditions present upon
macrophage activation would facilitate the conversion of QBP,
which does not bind Cu, to the Cu-chelating ionophore 8HQ (Fig-
ure 1A). QBP is stable in aqueous solutions between pH 5 and 8,
although some hydrolysis of the pinanediol occurs at lower and
higher pH values, leaving quinoline boronic acid (QBA), a mole-
cule that remains ill equipped to bind metals (Dickens and Franz,
2010). We previously showed that boronate-based prochelators
such as QBP and QBA require interaction with specific oxidative
species of either H2O2 or peroxynitrite (OONO
) to convert to
their metal-binding phenol derivative (Kielar et al., 2012; Sikora
et al., 2011). QBP, originally conceived in the context of Alz-
heimer’s disease, converts to the [Cu(8HQ)2] complex when
reacted in vitro with a peroxide-generating combination of amy-
loid-beta peptide and Cu (Dickens and Franz, 2010).978 Chemistry & Biology 21, 977–987, August 14, 2014 ª2014 ElseviHere we activate murine RAW 264.7 macrophage-like cells
(RAW cells) with LPS and IFN-g treatment. Both naive and acti-
vated RAW cells were incubated with 200 mM QBP overnight,
and the amount of converted 8HQ was quantitated by liquid
chromatography and mass spectrometry (LC-MS) (Figure 1B;
Figures S1 and S2 available online). Samples from naive RAW
cells provided LC-MS chromatograms showing the presence
of QBP but only trace quantities of 8HQ, which were not signifi-
cantly different from the 4 mM detection limit of the cell-free con-
trol (Figure 1B; Figure S2). However, samples from activated
RAW cells provided chromatograms with a mass signal consis-
tent with the presence of about 20 mM8HQ, indicative of approx-
imately 10% QBP conversion and indicating that the niche of
activated macrophage-like cells is suitable to convert QBP to
8HQ (Figure 1B).
QBP and 8HQ Display Differential Toxicity to RAW Cells
The Cu-dependent cytotoxic effects of 8HQ have been docu-
mented in a number of cell lines (Darby and Nathan, 2010; Tar-
dito et al., 2012). Because the metal-binding capacity of 8HQ
ismasked in QBP, we reasoned that QBP has diminished toxicity
compared with 8HQ. In culture media without supplemental
Cu, naive RAW cells were not viable in 8HQ concentrations
above 12.5 mM but tolerated QBP at concentrations as high as
100 mM, the highest dose tested. Upon coaddition with 10 mM
CuSO4, viability was lost at concentrations of 0.8 mM 8HQ and
higher. In contrast, naive RAW cells remained viable at all com-
binations of Cu and QBP, with a slight decrease at the highest
100 mM dose of QBP (Figure 1C).
Activated RAW cells cultured with Cu also showed 8HQ-
dependent cytotoxicity but were even more sensitive, with a
cytotoxic threshold occurring at 0.4 mM 8HQ (Figure 1D). As ex-
pected, activated RAW cells cultured with both Cu and QBP
showed a dramatic decrease in viability (Figure 1D), supporting
previous data that activated macrophages stimulate conversion
of QBP to 8HQ to elicit Cu-dependent killing.
8HQ and Peroxide-Activated QBP Are Antifungal in the
Presence of Cu
Consistent with previous reports (Ding et al., 2013), we found
that C. neoformans grows normally in culture supplemented
with 1 mM Cu (Figure 2A), which is much higher than what
many cell types withstand. Without supplemental Cu, the mini-
mal inhibitory concentration (MIC) of 8HQ that prevents
C. neoformans growth is 400 mM (Table 1). However, the combi-
nation of 5 mM 8HQ with either high (1 mM) or low (10 mM) con-
centrations of Cu inhibits growth (Figure 2A; Figure S4). With
supplementation of 1, 10, and 100 mM Cu, the MIC values for
8HQ decrease to 50, 6, and 6 mM, respectively (Table 1). In
contrast to 8HQ, neither 6-hydroxyquinoline (6HQ), an isomer
of 8HQ that does not bind Cu, nor QBP inhibits growth at con-
centrations as high as 400 mM in the presence of 1 mM Cu (Fig-
ure 2A; Figure S3).
The ineffectiveness of 6HQ and QBP to inhibit growth empha-
sizes the importance of Cu binding as a critical property of 8HQ’s
antifungal activity. To ascertain if QBP can be conditionally
converted to 8HQ and bind Cu to inhibit C. neoformans growth
in vitro, 100 mM QBP was coincubated with 10 mM Cu and
increasing concentrations of H2O2. In the presence of 250 mMer Ltd All rights reserved
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Figure 1. QBP Is Converted to 8HQ in RAW 246.7
Macrophages
(A) Schematic of the reaction of prochelator QBP, which
contains a pinanediol boronic ester masking group that
blocks metal binding, with hydrogen peroxide (or per-
oxynitrite) giving the metal-binding agent 8HQ (nontoxic
boric acid and pinanediol side products not shown).
Other compounds used in this study include 6HQ, in
which the position of the OH eliminates the O,N
chelating motif that makes 8HQ an effective agent for
binding a range of di- and trivalent metal ions, and BCS,
a Cu(I) chelator.
(B) Plot showing the concentration of 8HQ detected by
LC-MS analysis of RAW 246.7 cells treated with 200 mM
QBP overnight. Whereas 8HQ was detected at appre-
ciable levels in activated RAW 264.7 cells, 8HQ was not
observed above the limit of detection in naive cells or
cell-free medium (DMEM). Cells were activated with
30 mg/ml of LPS and 5 ng/ml of IFN-g. Error bars
represent SD.
(C and D) Viability plots of RAW 264.7 macrophage-like
cells. Cell viability of naive (C) and activated (D) RAW
cells in the presence or absence of 10 mM supplemental
CuSO4 and increasing concentrations of 8HQ or QBP.
Error bars represent SD.
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Figure 2. Effects of Cu, 8HQ, QBP, and H2O2
on C. neoformans Growth
(A and B) Growth, as monitored by optical density
after 60 hr, of WT C. neoformans H99 strain grown
in SC medium at 30C with (A) 8HQ, QBP with or
without 1 mM CuSO4 (B) 100 mM QBP and 10 mM
CuSO4 with indicated concentrations of hydrogen
peroxide. 8HQ plus Cu inhibits growth, while QBP
requires stimulatory H2O2 to have an effect,
consistent with prochelator-to-chelator conver-
sion under these conditions.
(C) BCS at various concentrations and in combi-
nation with 5 mM 8HQ and 10 mM CuSO4. BCS
reverses the growth inhibition of 8HQ plus Cu.
(D) UV-visible spectra of 100 mM 8HQ and 50 mM
CuSO4 in SC media with increasing concentra-
tions of BCS from 0 to 500 mM. Error bars repre-
sent SD.
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became antifungal (Figure 2B). H2O2 at these concentrations,
alone or with Cu, did not inhibit growth of C. neoformans (Fig-
ure 2B); therefore, this activity cannot be attributed simply to
H2O2 and Cu reactivity. Although the concentration of H2O2
resulting from this bolus dose appears higher than would be ex-
pected in a macrophage, its effective concentration likely dimin-
ishes rapidly as a result of enzymatic consumption and does not
mimic the persistent peroxide generation that occurs during
macrophage activation (Antunes and Cadenas, 2000). Regard-
less of these considerations, our observation that QBP converts
to 8HQ upon macrophage activation argues that the reactive
oxygen species (ROS) produced by these cells are sufficient
for activating QBP (Figure 1B). Combined, these data support
the hypothesis that 8HQ, converted from peroxide-activated
QBP, interacts with Cu in a manner that inhibits growth of
C. neoformans.
Metal specificity of 8HQ-dependent antifungal activity was
determined by growth in the presence of sublethal (10 mM)
concentrations of Cu(II), Zn(II), Fe(III), and Ag(I) (Figure S4).
C. neoformans growth was not inhibited by Fe(III) at any of the
8HQ concentrations tested. The addition of Zn(II) or Ag(I) with
100 mM 8HQ prolonged the transition from lag-phase to expo-
nential growth. None of these metals demonstrated a synergistic
antifungal effect with 8HQ as observed with Cu.
As further validation of the Cu requirement on 8HQ toxicity, the
cell impermeable Cu(I) chelator bathocuproine disulfonic acid
(BCS) showed a dose-dependent ability to restore growth of
C. neoformans in the presence of inhibitory concentrations of
Cu and 8HQ (Figure 2C). To bolster the assumption that this
result was due to BCS competing with 8HQ for binding Cu, a
solution of 100 mM 8HQ and 50 mM CuSO4 was prepared in syn-
thetic complete (SC) growth medium, and an absorption band
centered at 375 nm was observed spectrophotometrically as a
characteristic feature of Cu(II) complexation by 8HQ (Figure 2D).
Addition of BCS resulted in the dose-dependent appearance980 Chemistry & Biology 21, 977–987, August 14, 2014 ª2014 Elsevier Ltd All rights reservedof a new absorption band centered at
483 nm, a characteristic feature of the
[Cu(BCS)2]
3 complex. These data reveal
that BCS competes with 8HQ for bindingCu, which is readily reduced from Cu(II) to Cu(I) upon BCS
binding.
8HQ-Cu Complexes Are Fungicidal
To determine whether 8HQ-Cu is fungicidal or fungistatic,
C. neoformanswas incubated with 8HQor 8HQplus Cu, and col-
ony-forming units (cfu) were quantitated for each condition after
24 hr. Fungi grown in medium containing up to 100 mM 8HQ
without Cu were able to replicate. With coadministration of
10 mM Cu, replication was observed only for concentrations of
8HQ lower than the MIC value (Figure 3A). No viable fungi were
detected for higher concentrations of 8HQ in combination with
10 mMCu (Figure 3A). Moreover, after 3 hr, we observed a reduc-
tion in the number of colonies recovered from cultures containing
10 mM 8HQ and 10 mM Cu, whereas untreated C. neoformans
cells were able to propagate (Figure 3B), suggesting that the
8HQ-Cu combination is a fast-acting fungicide.
8HQ Increases Cellular Cu Accumulation and
Bioavailability
To evaluate the effect of 8HQ on metal allocation, total metal
content of C. neoformans cells was measured by inductively
coupled plasma mass spectrometry (ICP-MS). Figure 4A shows
that treatment of C. neoformans with 8HQ and Cu together re-
sults in 40 times more cell-associated Cu than treatment with
equivalent amounts of Cu alone. Incubation with QBP under
the same conditions did not increase C. neoformans-associated
Cu, consistent with the absence of Cu-binding activity by QBP.
In addition, cell-associated Zn and Fe levels were unchanged
in conditions tested, providing further evidence for Cu specific
action of 8HQ (Figure S5).
The ICP-MS data, combined with the differential effects on
fungal growth to the extracellular chelator BCS versus the cell
permeable ionophore 8HQ, endorse a mechanism of action
whereby 8HQ increases intracellular Cu. Consistent with this hy-
pothesis, a C. neoformans strain lacking the Cu-detoxifying MT
Table 1. MICs of 8HQ and QBP in the Presence of Varying
Concentrations of Cu
Organism
8HQ QBP
0 mM
Cu
1 mM
Cu
10 mM
Cu
100 mM
Cu
100 mM
Cu
C. neoformans 400 50 6 6 >400
C. glabrata 500 50 12 6 >400
S. aureus 100 25 12 6 >400
E. coli 100 100 200 —a >400b
S. typhimurium 400 400 200 100 >400
MIC represented in micromolar compound.
aE. coli was unable to grow in 100 mM Cu in M9 minimal media.
bIn M9minimal media, E. coliwas unable to grow in 100 mMCu. The value
presented here is in the presence of 10 mM Cu.
A
B
Figure 3. 8HQ-Cu Combination Is Fungicidal
(A) The cfu obtained from samples of C. neoformans initially grown in liquid SC
medium containing indicated concentrations of 8HQ with or without supple-
mental CuSO4 for 24 hr.
(B) Time course of cell replication as measured by the number of
C. neoformans colonies formed after incubation in SC medium without treat-
ment or with the addition of 10 mM 8HQ and 10 mM CuSO4. The fungicidal
effect of 10 mM8HQ plus 10 mMCuSO4 on fungal growth occurs within the first
3 hr of treatment, as shown by a steady decrease in the recovery of viable cfu.
Error bars represent ±SEM in (A) and SD in (B).
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to treatment with 8HQ (Ding et al., 2013). In SC medium with
trace Cu, the cmt1Dcmt2D mutant grows equivalently to the
isogenic wild-type (WT) parental strain. However, addition of
8HQ partially inhibits growth of the cmt1Dcmt2D mutant at
6.25 mM8HQand completely inhibits at 12.5 mM8HQ (Figure 4B).
The reciprocal experiment was performed using a
C. neoformans mutant lacking the functionally redundant high-
affinity Cu(I) importers Ctr1 and Ctr4 (Ding et al., 2011). Growth
of C. neoformans in YPEG medium containing ethanol and glyc-
erol as sole carbon sources requires Cu for cytochrome oxidase-
dependent respiration. Although WT cells grow in YPEG, the
ctr1Dctr4Dmutant does not (Ding et al., 2011). However, growth
of this mutant was restored to near WT levels by addition of
6.25 mM 8HQ (Figure 4C). These results suggest that 8HQ
shuttles Cu present in the growth medium into cells, bypassing
the Ctr1- and Ctr4-dependent Cu(I) import mechanisms and
rendering Cu bioavailable for cytochrome oxidase.
On the basis of this Cu shuttling activity, we predicted that 8HQ
would activate the Cu-sensing transcriptional activator Cuf1,
leading to increased expression of CMT1. Consistent with pub-
lished reports (Ding et al., 2011), CMT1 expression increased
with increasing Cu and was unchanged in response to Cu limita-
tion by BCS, as determined by quantitative real-time PCR (Fig-
ure 4D). Compared with modestCMT1 gene activation observed
upon treatment of cellswith 10mMCualone (17-fold), treatment
with 10 mM 8HQ in addition to Cu resulted in a strongly synergis-
tic 460-fold CMT1 induction. The addition of 100 mM QBP
along with 10 mM Cu, on the other hand, resulted in only a
29-fold induction, similar to Cu alone. These results suggest
thatC. neoformans responds to and mounts a high-Cu response
in the presence of 8HQ by increasing expression of CMT1.
8HQ-Cu Has Broad-Spectrum Antimicrobial Activity
To assess the possible broad-spectrum applicability of the QBP
strategy, we tested the effects of 8HQ against other pathogens
in vitro. The fungal commensal and opportunistic pathogen of
mucosal surfaces,Candida glabrata, was treated with increasing
concentrations of 8HQ or QBP in the presence of increasing
Cu and monitored for growth to determine the MIC. Similar to
the results observed with C. neoformans, QBP did not inhibit
growth, whereas 8HQ inhibited growth upon increasing the con-Chemistry & Biology 21, 97centration of Cu (Table 1). In the absence of supplemental Cu,
the concentration required for 8HQ alone to prevent growth of
C. glabrata was 400 mM, but the MIC decreased to 50, 12.5,
and 6.25 mM in the presence of 1, 10, and 100 mM CuSO4,
respectively, revealing that 8HQ is similarly effective against
C. glabrata compared with C. neoformans.7–987, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 981
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Figure 4. 8HQ Transports Cu into
C. neoformans
(A) Plot of the amount of Cu detected by ICP-MS
analysis of WT C. neoformans treated with or
without various combinations of CuSO4 and/or
compound, as indicated. The combination of
10 mM 8HQ and 10 mM CuSO4 increases cell-
associated Cu significantly more than 100 mM
CuSO4 alone (notice the break in the y axis).
(B) Comparison of the growth ofWTC. neoformans
with the double MT knockout strain cmt1Dcmt2D
as a function of 8HQ concentration in SC media.
The growth defect of the mutant strain at concen-
trations of 8HQ that are well tolerated by the WT
suggests that MTs are required to tolerate the
increased Cu stress promoted by 8HQ.
(C) Growth comparison of WT C. neoformans
versus the ctr1Dctr4D strain as a function of 8HQ
concentration in YPEG medium without Cu sup-
plementation. Without a cell-surface Cu trans-
porter to import Cu, ctr1Dctr4D cells are unable to
grow in these conditions. 8HQ overcomes this
growth defect, suggesting that 8HQ transports
trace Cu from the medium.
(D) The relative expression level, as quantified by
quantitative PCR, of the MT gene CMT1 as a
function of the indicated concentrations of
CuSO4, BCS, 8HQ, or QBP. The strength of CMT1
induction increases with concentration of Cu. As a
control, the extracellular Cu(I) chelator BCS does
not lead to a change in CMT1 expression. 8HQ
and QBP (10 mM) alone do not cause robust in-
duction of CMT1, while 8HQ plus Cu (10 mM each)
leads to CMT1 levels greater than what is
observed with 100 mM CuSO4 alone. ICP-MS and
expression data are represented by SEM; error
bars in growth assays represent SD.
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example of Gram-positive bacteria (Table 1). As was the case
with the two fungi, S. aureus failed to grow in the presence of
8HQ and increasing concentrations of supplemental Cu. For
this bacterium, the MIC shifted to lower concentrations of 8HQ
as the concentration of Cu increased, with the lowest MIC being
the combination of 6.25 mM 8HQ with 100 mM CuSO4, similarly
susceptible to the 8HQ-Cu combination when compared with
the two fungi.
Two Gram-negative bacteria, Escherichia coli and Salmonella
typhimurium, were tested against 8HQ and QBP (Table 1); these
organisms responded to treatment with 8HQ differently than
the other pathogens. The MIC of 8HQ for these organisms was
R100 mM 8HQ at all concentrations of supplemental Cu, sug-
gesting either a different antimicrobial mechanism of 8HQ or
an enhanced resistance mechanism of these bacteria. These re-
sults demonstrate that 8HQ has broad-spectrum antimicrobial
activity, with the level of in vitro activity varying by organism.
QBP Enhances the Fungicidal Activity of Activated
RAW Cells
Given that 8HQ and Cu are fungicidal to C. neoformans, and that
activated macrophages convert QBP to 8HQ, the impact of QBP
onC. neoformans viability in the presence of activated RAW cells
was evaluated. We observed a dose-dependent reduction in
C. neoformans cfu when activated RAW cells were treated with982 Chemistry & Biology 21, 977–987, August 14, 2014 ª2014 ElseviQBP.C. neoformans showed 41%survival after 6 hr of coincuba-
tion with activated macrophages and 200 mM QBP with 2 mM
supplemental Cu (Figure 5A). However, 91% of C. neoformans
survived when treatedwith QBP in the absence of macrophages,
confirming that killing ofC. neoformans byQBPwasmediated by
the action of RAW cells. As expected, treatment with 20 mM 8HQ
was fungicidal but concurrently reducedRAWcell viability aswell
(Figure 5B). Importantly, the reduction in C. neoformans prolifer-
ation in the presence of activated RAW cells and QBP did not
diminish the viability of RAW cells (Figure 5B). In these coculture
assays, expression ofCMT1 increased as a function of QBP con-
centration, with 10-fold induction of the MT at the highest con-
centration of QBP tested (200 mM) (Figure 5C). Treatment with
20 mM 8HQ resulted in a 100-fold induction of CMT1. Although
Figure 5A indicates that therewere no viable cells recovered after
coculture for 6 hr upon 8HQ treatment in a 96-well format, we
were still able to recover RNA when the assay was adapted to a
6-well format for RNA isolation. These data further support the
evidence that QBP conversion to 8HQ by macrophages leads
to an increased Cu response by C. neoformans, highlighting a
role of Cu overload in its antifungal activity.
QBP Reduces Fungal Burden during Mouse
Lung Infection
To test the effect of QBP on the burden of C. neoformans in a
mouse model of lung infection, we intranasally infected mice.er Ltd All rights reserved
AB C
Figure 5. QBP Aids Killing of C. neoformans by Macrophages
(A) Comparison of the survival of C. neoformans in the absence or presence of
activated RAW 264.7 cells (MOI = 1:10).C. neoformans viability was quantified
6 hr after incubation at 37C by enumeration of cfu produced for each con-
dition. No C. neoformans cells were recovered upon treatment with 8HQ. A
statistically significant reduction in the survival ofC. neoformanswas detected
when cocultured with macrophages and 200 mM QBP compared with QBP in
cell-freemedium, suggesting that themacrophages convert QBP to 8HQ. Data
are represented as mean ± SEM (***p < 0.001).
(B) Cell viability of the infected and treated macrophages described in (A).
Whereas 8HQ was toxic, QBP was not toxic at any concentration tested, even
at 200 mM, which was shown in (A) to reduce C. neoformans survival.
(C) Expression of CMT1 in C. neoformans cocultured with macrophages in the
same conditions as in (A) and (B) increases as the concentration of QBP rises
and correlates with the observed antifungal activity in (A). All error bars rep-
resented are SEM.
A
B
Figure 6. Mice Treated with QBP Have a Decreased Fungal Burden
(A) Schematic of the treatment regimen for three groups of animals (each with
n = 7) on indicated days. Treatment group 1 received DMSO vehicle control
(1% DMSO, PBS) from day 1 to day 2, treatment group 2 received DMSO
vehicle control fromday1 to day 1 and then one final dose of 5mg/kgQBP on
day 2, and treatment group 3 received 5 mg/kg QBP from day 1 to day 2.
Data are presented as mean ± SEM (*p < 0.05).
(B) On day 3, lungs were harvested from mice, and the cfu per lung were
enumerated by homogenizing the entire organ and plating a dilution series on
SC medium.
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and two treatment groups that received different dosing regi-
mens of QBP. The control group was given four doses of PBS/
1% DMSO vehicle: one the day before infection, one the day
of infection, and two doses after infection (Figure 6Ai). One treat-
ment group received only one dose total of QBP on day 2 (5 mg/
kg QBP, 50 ml intranasal dose), administered 2 days after infec-
tion (Figure 6Aii), while the second treatment group received four
QBP doses (5 mg/kg QBP, 50 ml intranasal dose) the day beforeChemistry & Biology 21, 97infection, the day of infection, and doses 1 and 2 days after
infection (Figure 6Aiii). At 3 days after infection, the lungs were
harvested to quantify the remaining cfu of C. neoformans.
Compared with PBS control, mice receiving four doses of QBP
had a significantly reduced fungal burden in their lungs (Fig-
ure 6B). The animals that received only one dose of QBP the
day prior to lung harvest did show a decrease in fungal burden,
but this was not significant (Figure 6B). QBP was active in the
mouse lung, resulting in a reduction in the number of viable
C. neoformans cells, suggesting that it is converted to the anti-
fungal compound 8HQ in the context of an infected lung.
On the basis of reports that the immune response and immune
cell counts can be perturbed by either high or low levels of serum
Cu (Kelley et al., 1995; Pocino et al., 1991), we sought to deter-
mine if administration of QBP or 8HQ had any observable effects7–987, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 983
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ally daily with QBP, 8HQ, or a DMSO control over the course of
2 weeks, after which complete blood counts revealed that there
was no significant change in various cell types (lymphocytes,
monocytes, eosinophils, and basophils) (Figure S6). Further-
more, no appreciable changes in weight were observed for
mice treated with QBP or 8HQ. Combined, these results provide
preliminary evidence that these doses of QBP have no adverse
effects in mice in the conditions tested.
DISCUSSION
In the face of escalating antibiotic resistance and lethal fungal
infections, there is a clear need for new strategies to identify anti-
microbial therapeutics with minimal toxicity to host cells. Cu
mobilization is used by the immune system to kill pathogens,
but these pathogens have developed mechanisms to cope
with elevated Cu. The results presented here provide a strategy
for the development of compounds that exploit the activated im-
mune response and override Cu detoxification machinery in
fungal and bacterial pathogens, thereby boosting antimicrobial
activity by the host. The prodrug QBP takes advantage of two
prongs of the immune response, the first being the increase of
ROS in phagolysosomes and surrounding tissues that convert
QBP to 8HQ. We show by analytical methods that QBP is
nontoxic and remains intact in naive RAWmacrophages but con-
verts to 8HQ in activated cells. The second element of the im-
mune system responsible for activating QBP is the mobilization
of Cu during infection to facilitate formation of antimicrobial
8HQ-Cu complexes. It is unclear if the antimicrobial Cu used
by macrophages derives from intracellular stores or extracellular
recruitment. Although no direct role in Cu donation has been
reported, the major Cu-containing protein in the plasma, cerulo-
plasmin, is elevated during infection and inflammation, poten-
tially providing a source of Cu to immune cells (Bakhautdin
et al., 2013; Conforti et al., 1982). In principle, these two require-
ments for efficacy of QBP as a prodrug endow it with a unique
conditional antimicrobial activity that focuses the toxicity of
8HQ to sites of infection. Although we cannot conclude that
the activity of QBP in the mouse is Cu dependent, data from
our in vitro experiments strongly support this hypothesis.
C. neoformans, a fungal pathogen that causes lethal meningitis
in humans, expresses several Cu-dependent enzymes, including
laccase for melanin production, Cu/Zn superoxide dismutase for
superoxide disproportionation and multi-Cu oxidases for Fe up-
take. Although the presence of these proteins implies a require-
ment forCuacquisition,conditionsofacuteCudeprivationcreated
by BCS in culturemedia do not limit growth.C. neoformans grows
equally well in high or low Cu conditions, and it is striking that low
concentrations of Cu combined with 8HQ kill C. neoformans. We
present evidence that this fungicidal effect is due to 8HQ’s iono-
phoric properties,which increasecell-associated andbioavailable
Cu and strongly induce Cu-responsive transcription.
Although both BCS and 8HQ bind Cu by forming five-
membered chelate rings, significant differences in the chemistry
of these Cu-chelate complexes directly relate to their observed
biological activity. BCS enforces anionic tetrahedral Cu(I) com-
plexes, of formula [Cu(BCS)2]
3, that resist aerial oxidation and
remain extracellular. Its much greater affinity for Cu(I) than984 Chemistry & Biology 21, 977–987, August 14, 2014 ª2014 ElseviCu(II) (log b2 = 19.8 versus 11.8, respectively) makes BCS an
excellent reagent for limiting Cu bioavailability via sequestration
of Cu(I) (Xiao et al., 2011). On the other hand, 8HQ forms neutral,
flat, square planar complexes with Cu(II), of formula [Cu(8HQ)2],
that can permeate cell membranes. Although its overall affinity
for Cu(II) predicts strong binding (log b2 = 26.2) (Johnston and
Freiser, 1952), 8HQ has negligible affinity for Cu(I), suggesting
that Cu can be transferred via reductive transmetalation from
8HQ to a Cu(I) binding agent, as we observed in the competition
experiment shown in Figure 2D. These properties categorize
8HQ as an ionophore that operates by increasing intracellular
bioavailable Cu. Corroborating the data presented here, the hy-
droxyquinoline derivative clioquinol increases the amount of cell
associated Cu in Saccharomyces cerevisiae, providing bioavail-
able Cu to the Sod1 chaperone Ccs1 (Li et al., 2010). Hyperin-
duction of CMT1 in the presence of 8HQ and Cu and recovery
of growth of the ctr1Dctr4D mutant by 8HQ suggest that 8HQ
similarly supplies Cu in a bioavailable form to C. neoformans.
Our results show that 8HQ-derived Cu evades the normally
robust Cu tolerance and detoxification mechanisms used by
C. neoformans to survive in Cu-rich environments in vitro. We
recently reported that pulmonary infection of mice with
C. neoformans resulted in induction of the CMT genes, which
are essential for virulence (Ding et al., 2013). These in vivo results
in combination with the data presented here suggest that phar-
macologically targeting the mechanisms of C. neoformans for
Cu tolerance may be a promising antifungal strategy.
The mechanistic details of how Cu, supplied by 8HQ, evades
the C. neoformans Cu maintenance machinery to induce
toxicity remain to be elucidated. Perhaps increased oxidative
stress driven by Fenton-type reactions, or displacement of
metals from physiological protein coordination sites, in particular
exposed Fe-sulfur clusters, plays a role in 8HQ-Cu toxicity (Ma-
comber et al., 2007; Valko et al., 2005). Both possibilities suggest
that Cu is released from 8HQ in cells, a probable scenario given
that the reducing intracellular environment favors reduction of
Cu(II) to the more labile Cu(I), which would dissociate from
8HQ. An alternative, or perhaps synergistic, activity could result
from the liberation of free 8HQ inside the cell, which could
then bind other metals or inhibit metalloenzymes, as has been
observed in some cases (Baum et al., 2007; Fraser and Creanor,
1975). Yet another possibility is that intact [Cu(8HQ)2] complexes
are a source of toxicity. Molecules in the hydroxyquinoline family
have been suggested to inhibit the proteasome as intact, neutral
complexes that induce cell death (Cater and Haupt, 2011; Daniel
et al., 2005; Tardito et al., 2012; Zhai et al., 2010). Although such
pathways have not beenwell characterized inC. neoformans, we
cannot rule them out for the fungicidal activity of 8HQ and Cu.
However, the strong transcriptional response of CMT1 gives
weight to a role for Cu toxicity being driven mostly by released
Cu, not intact [Cu(8HQ)2] complexes.
Treatment of a panel of bacterial and fungal pathogens
showed that 8HQ has potential to be broadly antimicrobial.
The differing sensitivity of organisms to 8HQ-Cu cotreatment re-
mains an interesting subject for further investigation, as the anti-
microbial mechanisms against prokaryotes and eukaryotes may
be different. The fungi and Gram-positive organisms tested here
appear to be sensitive to the 8HQ and Cu combination at similar
levels. S. aureus appears to be more sensitive to Cu aloneer Ltd All rights reserved
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300 mM versus 2.5 mM, respectively) (Baker et al., 2010; Ding
et al., 2013). The two Gram-negative bacteria were less sensitive
to 8HQ than the other organisms tested in our study, and this
toxicity was independent of exogenous Cu (Table 1). The acid-
fast bacteriumMycobacterium tuberculosis has alsobeen shown
to be sensitive to the effects of 8HQ, but a role for Cu was not
elucidated in that study (Darby andNathan, 2010). The antimicro-
bial properties of Cu-8HQmay be due to a combination of effects
that are specific to each organism, such as altered metabolism,
different effects of bioavailable Cu, species-specific targets of
8HQ, or differences in their Cu homeostasis machinery.
SIGNIFICANCE
In this work, we have laid the foundation for the utilization of
molecules thatareconditionallyactivated in thenicheof infec-
tion tobindCuandoverride theCudetoxificationmachineryof
microbial pathogens. In doing so, thesemolecules utilize and
bolsterkeyaspectsof the immunesystemtokill fungi yetmini-
mize cytotoxicity to the host. Discovery of new antifungal
drugs is notoriously difficult because of the biochemical sim-
ilarities of typical drug targets between eukaryotic pathogens
and eukaryotic host cells. QBP exploits the unique chemical
milieu created by the host in an antifungal targeting strategy.
Furthermore, this work represents an important advance in
developingbroad-spectrumantimicrobial agentson thebasis
of Cu biology. Because Cu homeostasis is a universal aspect
ofbiology,microbeshavedevisedanumberofways tosurvive
when faced with increased Cu during infection. Small mole-
cules that sneak Cu through these biochemical checkpoints
therefore provide a powerful paradigm for targeting a broad
spectrum of pathogens. Furthermore, both pathogenic and
commensal microorganisms have evolved to deal with metal
availability in general that is controlled by the host. Prochela-
tors that are optimized for different metals or under different
activating conditions may therefore enable selective redistri-
butionofmetalsmorebroadly, andnot justatsitesof infection
but in other disease states as well.
EXPERIMENTAL PROCEDURES
Detailed outline of experimental procedures for LC-MS detection of QBP and
8HQ, fungicidal assay, UV-visible analysis, ICP-MS analysis, quantitative real-
time PCR, and intraperitoneal mice experiments are outlined in Supplemental
Experimental Procedures.
Strains and Media
C. neoformans H99 and C. glabrata strains were streaked onto solid SC me-
dium (MP Biomedicals) from frozen stocks stored at 80C. For experiments,
one colony was picked and grown in an overnight culture of SCmedium. Over-
night cultures were diluted, washed, or aliquoted as appropriate for the exper-
imental protocols described below. E. coli and S. typhimurium ser. typhimu-
rium strains were maintained on Luria broth solid medium and grown in
liquid M9 minimal medium. S. aureus Newman strain was grown on tryptic
soy broth (BD Biosciences) for the duration of experiments. MIC experiments
were performed in triplicate in 96-well plate format in the media stated above.
Growth Curves
The broth microdilution method described by the Clinical and Laboratory
Standards Institute, with minor modifications for Cryptococcus, was used toChemistry & Biology 21, 97determine the susceptibility of strains in this study. Briefly, C. neoformans cul-
tures in liquid SCmedium were inoculated from a single colony grown on solid
SCmediumand incubated overnight at 30Cwith shaking at 200 rpm. Cell sus-
pensions were diluted to an optical density at 600 nm (OD600) of 0.002 with
fresh SC medium and aliquoted into 96-well plates. Test compounds were
added from DMSO stock solutions to final concentrations ranging from 400
to 0.4 mM, with <0.5% DMSO. For each test run, a compound-free positive
growth control and a cell-free negative control were included. For experiments
using added metal ions, fresh stock solutions of CuSO4, ZnCl2, ferric ammo-
nium citrate, and AgNO3 were prepared in deionized water and added to
appropriate wells at final concentrations as indicated in figure legends. Plates
were incubated at 30C and read every 4 hr for 48 hr. Growth curves were
generated by plotting OD600 readings versus time. All tests were performed
in triplicate for each condition in a single experiment, and two separate exper-
iments were carried out. MIC was defined as the lowest concentration of com-
pound at which growth was not detected at 24 hr.
Cell Culture
The mouse RAW 264.7 macrophage-like cell line obtained from the Duke Cell
Culture Facility was maintained, and experiments were carried out, unless
otherwise noted, in supplemented Dulbecco’s modified Eagle’s medium
(DMEM)with 4.5 g/L D-glucose (Gibco, Invitrogen) and 10% fetal bovine serum
(FBS), 100 U penicillin-streptomycin, at 37C and 5% CO2. Experiments were
carried out on cells passaged between three and ten times. For experiments
requiring activated macrophages, IFN-g and LPS (Sigma-Aldrich) were added
simultaneously with the compound treatments at final concentrations of 5 ng/
ml and 30 mg/ml, respectively. Concentrations used were determined empiri-
cally by treating RAW cells with increasing amounts of these activators and
assessing the fluorescence response of the resulting oxidation of 20,70-dichlor-
odihydrofluorescein diacetate oxidation.
Cytotoxicity Assay
Macrophages were seeded in 100 ml of supplemented DMEM at 2.5 3 105
cells/ml in a 96-well plate. Aliquots of 8HQ, QBP, and CuSO4 were added to
final concentrations as indicated in figure legends. The concentration of
DMSO as treatment vehicle was adjusted to 0.1% in all wells, including the
no-treatment control. Plates were incubated at 37C, and cell viability was
assessed after 24 hr by using the Cell Titer Glo assay (Promega), per the man-
ufacturer’s protocol. All tests were performed in triplicate for each condition in
a single experiment, and two separate experiments were carried out.
Macrophage Coculture Assay
Macrophages were seeded in 100 ml of supplemented DMEM at 2.5 3 105
cells/ml in a 96-well plate and incubated at 37C. After 24 hr, the growth me-
dium was removed, cells were washed 2 times with PBS buffer (pH 7.4), and
cells were activated by the addition of IFN-g (5 ng/ml) and LPS (30 mg/ml) in
100 ml of nonsupplemented DMEM with 4.5 g/LD-glucose. Cells were simulta-
neously treated with 2 mMCuSO4 and indicated concentrations of 8HQ or QBP
in DMEM without FBS supplementation. Cells were infected immediately with
C. neoformans (H99) at a multiplicity of infection (MOI) of 1:10 (macrophage/
yeast). After a 6 hr incubation at 37C, the cell medium of infected macro-
phages was removed and saved. Macrophages were lysed with 0.1% Triton
X-100 in deionized water, and lysates were combined with spent medium pre-
viously collected. Dilutions of this preparation were plated on solid SC, and cfu
were enumerated after incubation at 30C for 2 days. Coculture experiments in
which RNAwas isolated for quantitative real-time PCR analysis were designed
in the same manner, with the exception of being performed in 6-well plates, as
detailed in Supplemental Experimental Procedures.
Animal Infection and Treatment with QBP
Female A/Jmice were purchased from the National Cancer Institute at age 4 to
6 weeks. Themice were given a week to acclimate at Duke facilities. Infections
were carried out according to published protocols (Crabtree et al., 2012).
Doses (50 ml/day) of PBS control (1% DMSO dissolved in PBS) or QBP
(5 mg/kg equivalent dissolved in PBS) were administered intranasally to anes-
thetized mice (250 mg/kg tribromoethanol; Avertin). The dose of QBP admin-
istered to mice was determined as the maximal amount soluble in a 50 ml
preparation.7–987, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 985
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The error bars in all growth curves and cytotoxicity assays represent the SD of
an experiment done in triplicate. The conversion of QBP to 8HQ in macro-
phages error bars represents the SD of at least six samples per treatment
over two different passages of macrophages. In the fungicidal assays, ICP-
MS assay, and macrophage coculture assays, the error bars represent the
SEM from three experiments. In the animal infection experiment, the error
bars represent the SEM of seven mice per group. One-way ANOVA was per-
formed to determine significance for macrophage coculture assay and for
animal infection experiments.
Ethics Statement
All experiments involving animals were approved by the Institutional Animal
Care and Use Program (protocol number A013-13-01) at Duke University.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.chembiol.2014.06.009.
AUTHOR CONTRIBUTIONS
R.A.F. and M.E.H. designed and performed experimental assays. K.J.F. and
D.J.T. designed and supervised this study. All authors reviewed and inter-
preted data and provided input in writing and reviewing the manuscript.
ACKNOWLEDGMENTS
We gratefully acknowledge Kim Hutchison for running ICP-MS samples at
North Carolina State University, Raleigh. We thank Dr. George Dubay for
thoughtful insight with the LC-MS experiments, Chen Ding for helpful sugges-
tions, and Andrew Franks for help with ROS fluorescence assays. This work
was supported by NIH grants GM100678-02 (R.A.F.), GM007105-40
(M.E.H.), GM041840 and AI106013 (D.J.T.), and GM084176 (K.J.F.).
Received: April 25, 2014
Revised: June 16, 2014
Accepted: June 23, 2014
Published: July 31, 2014
REFERENCES
Achard, M.E.S., Tree, J.J., Holden, J.A., Simpfendorfer, K.R., Wijburg, O.L.C.,
Strugnell, R.A., Schembri, M.A., Sweet, M.J., Jennings, M.P., and McEwan,
A.G. (2010). The multi-copper-ion oxidase CueO of Salmonella enterica sero-
var Typhimurium is required for systemic virulence. Infect. Immun. 78,
2312–2319.
Achard, M.E.S., Stafford, S.L., Bokil, N.J., Chartres, J., Bernhardt, P.V.,
Schembri, M.A., Sweet, M.J., and McEwan, A.G. (2012). Copper redistribution
in murine macrophages in response to Salmonella infection. Biochem. J. 444,
51–57.
Adlard, P.A., Cherny, R.A., Finkelstein, D.I., Gautier, E., Robb, E., Cortes, M.,
Volitakis, I., Liu, X., Smith, J.P., Perez, K., et al. (2008). Rapid restoration of
cognition in Alzheimer’s transgenic mice with 8-hydroxy quinoline analogs is
associated with decreased interstitial Abeta. Neuron 59, 43–55.
Andersen, A. (2006). Final amended report on the safety assessment of
oxyquinoline and oxyquinoline sulfate as used in cosmetics. Int. J. Toxicol.
25 (Suppl 1 ), 1–9.
Anderson, B.I., and Swaby, R.J. (1951). Factors influencing the fungistatic
action of 8-hydroxyquinoline (oxine) and its metal complexes. Aust. J. Sci.
Res., B 4, 275–282.
Antunes, F., and Cadenas, E. (2000). Estimation of H2O2 gradients across bio-
membranes. FEBS Lett. 475, 121–126.
Baker, J., Sitthisak, S., Sengupta, M., Johnson, M., Jayaswal, R.K., and
Morrissey, J.A. (2010). Copper stress induces a global stress response in986 Chemistry & Biology 21, 977–987, August 14, 2014 ª2014 ElseviStaphylococcus aureus and represses sae and agr expression and biofilm for-
mation. Appl. Environ. Microbiol. 76, 150–160.
Bakhautdin, B., Febbraio, M., Goksoy, E., de la Motte, C.A., Gulen, M.F.,
Childers, E.P., Hazen, S.L., Li, X., and Fox, P.L. (2013). Protective role of
macrophage-derived ceruloplasmin in inflammatory bowel disease. Gut 62,
209–219.
Baum, E.Z., Crespo-Carbone, S.M., Klinger, A., Foleno, B.D., Turchi, I.,
Macielag, M., and Bush, K. (2007). A MurF inhibitor that disrupts cell wall
biosynthesis in Escherichia coli. Antimicrob. Agents Chemother. 51,
4420–4426.
Bernstein, E.H., Pienta, P.W., andGershon, H. (1963). Acute toxicity studies on
8-quinolinol and some derivatives. Toxicol. Appl. Pharmacol. 5, 599–604.
Borkow, G., and Gabbay, J. (2005). Copper as a biocidal tool. Curr. Med.
Chem. 12, 2163–2175.
Butts, A., and Krysan, D.J. (2012). Antifungal drug discovery: something old
and something new. PLoS Pathog. 8, e1002870.
Cater, M.A., and Haupt, Y. (2011). Clioquinol induces cytoplasmic clearance of
the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for
prostate cancer. Biochem. J. 436, 481–491.
Conforti, A., Franco, L., Milanino, R., and Velo, G.P. (1982). Copper and ceru-
loplasmin (Cp) concentrations during the acute inflammatory process in the
rat. Agents Actions 12, 303–307.
Crabtree, J.N., Okagaki, L.H., Wiesner, D.L., Strain, A.K., Nielsen, J.N., and
Nielsen, K. (2012). Titan cell production enhances the virulence of
Cryptococcus neoformans. Infect. Immun. 80, 3776–3785.
Daniel, K.G., Chen, D., Orlu, S., Cui, Q.C., Miller, F.R., and Dou, Q.P. (2005).
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form pro-
teasome inhibitors and apoptosis inducers in human breast cancer cells.
Breast Cancer Res. 7, R897–R908.
Darby, C.M., and Nathan, C.F. (2010). Killing of non-replicatingMycobacterium
tuberculosis by 8-hydroxyquinoline. J. Antimicrob. Chemother. 65, 1424–1427.
Day, J.N., Chau, T.T.H., Wolbers, M., Mai, P.P., Dung, N.T., Mai, N.H., Phu,
N.H., Nghia, H.D., Phong, N.D., Thai, C.Q., et al. (2013). Combination anti-
fungal therapy for cryptococcal meningitis. N. Engl. J. Med. 368, 1291–1302.
Dickens, M.G., and Franz, K.J. (2010). A prochelator activated by hydrogen
peroxide prevents metal-induced amyloid b aggregation. ChemBioChem 11,
59–62.
Ding, C., Yin, J., Tovar, E.M.M., Fitzpatrick, D.A., Higgins, D.G., and Thiele,
D.J. (2011). The copper regulon of the human fungal pathogen
Cryptococcus neoformans H99. Mol. Microbiol. 81, 1560–1576.
Ding, C., Festa, R.A., Chen, Y.-L., Espart, A., Palacios, O`., Espı´n, J., Capdevila,
M., Atrian, S., Heitman, J., and Thiele, D.J. (2013). Cryptococcus neoformans
copper detoxification machinery is critical for fungal virulence. Cell Host
Microbe 13, 265–276.
Flannagan, R.S., Cosı´o, G., and Grinstein, S. (2009). Antimicrobial mecha-
nisms of phagocytes and bacterial evasion strategies. Nat. Rev. Microbiol.
7, 355–366.
Fraser, R.S.S., and Creanor, J. (1975). The mechanism of inhibition of ribonu-
cleic acid synthesis by 8-hydroxyquinoline and the antibiotic lomofungin.
Biochem. J. 147, 401–410.
Fu, Y., Tsui, H.-C.T., Bruce, K.E., Sham, L.-T., Higgins, K.A., Lisher, J.P.,
Kazmierczak, K.M., Maroney, M.J., Dann, C.E., 3rd, Winkler, M.E., and
Giedroc, D.P. (2013). A new structural paradigm in copper resistance in
Streptococcus pneumoniae. Nat. Chem. Biol. 9, 177–183.
Gonza´lez-Guerrero, M., Raimunda, D., Cheng, X., and Argu¨ello, J.M. (2010).
Distinct functional roles of homologous Cu+ efflux ATPases in Pseudomonas
aeruginosa. Mol. Microbiol. 78, 1246–1258.
Grass, G., Rensing, C., and Solioz, M. (2011). Metallic copper as an antimicro-
bial surface. Appl. Environ. Microbiol. 77, 1541–1547.
Hodgkinson, V., and Petris, M.J. (2012). Copper homeostasis at the host-path-
ogen interface. J. Biol. Chem. 287, 13549–13555.
Hood, M.I., and Skaar, E.P. (2012). Nutritional immunity: transition metals at
the pathogen-host interface. Nat. Rev. Microbiol. 10, 525–537.er Ltd All rights reserved
Chemistry & Biology
Activation of an Antifungal Agent by MacrophagesJohnston, W.D., and Freiser, H. (1952). Structure and behavior of organic
analytical reagents. III. Stability of chelates of 8-hydroxyquinoline and analo-
gous reagents. J. Am. Chem. Soc. 74, 5239–5242.
Kelley, D.S., Daudu, P.A., Taylor, P.C., Mackey, B.E., and Turnlund, J.R.
(1995). Effects of low-copper diets on human immune response. Am. J. Clin.
Nutr. 62, 412–416.
Kielar, F., Helsel, M.E., Wang, Q., and Franz, K.J. (2012). Prochelator BHAPI
protects cells against paraquat-induced damage by ROS-triggered iron chela-
tion. Metallomics 4, 899–909.
Leanderson, P., and Tagesson, C. (1996). Iron bound to the lipophilic iron
chelator, 8-hydroxyquinoline, causes DNA strand breakage in cultured lung
cells. Carcinogenesis 17, 545–550.
Li, C., Wang, J., and Zhou, B. (2010). The metal chelating and chaperoning
effects of clioquinol: insights from yeast studies. J. Alzheimers Dis. 21,
1249–1262.
Macomber, L., Rensing, C., and Imlay, J.A. (2007). Intracellular copper does
not catalyze the formation of oxidative DNA damage in Escherichia coli.
J. Bacteriol. 189, 1616–1626.
Milanino, R., and Buchner, V. (2006). Copper: role of the ‘endogenous’ and
‘exogenous’ metal on the development and control of inflammatory pro-
cesses. Rev. Environ. Health 21, 153–215.
Oliveri, V., Giuffrida, M.L., Vecchio, G., Aiello, C., and Viale, M. (2012).
Gluconjugates of 8-hydroxyquinolines as potential anti-cancer prodrugs.
Dalton Trans. 41, 4530–4535.
Percival, S.S. (1998). Copper and immunity. Am. J. Clin. Nutr. 67 (Suppl ),
1064S–1068S.
Pocino, M., Baute, L., andMalave´, I. (1991). Influence of the oral administration
of excess copper on the immune response. Fundam. Appl. Toxicol. 16,
249–256.
Samanovic, M.I., Ding, C., Thiele, D.J., and Darwin, K.H. (2012). Copper in mi-
crobial pathogenesis: meddling with themetal. Cell HostMicrobe 11, 106–115.
Sikora, A., Zielonka, J., Lopez, M., Dybala-Defratyka, A., Joseph, J., Marcinek,
A., and Kalyanaraman, B. (2011). Reaction between peroxynitrite and boro-
nates: EPR spin-trapping, HPLC Analyses, and quantum mechanical study
of the free radical pathway. Chem. Res. Toxicol. 24, 687–697.Chemistry & Biology 21, 97Solioz, M., Abicht, H.K., Mermod, M., and Mancini, S. (2010). Response of
gram-positive bacteria to copper stress. J. Biol. Inorg. Chem. 15, 3–14.
Tardiff, D.F., Tucci, M.L., Caldwell, K.A., Caldwell, G.A., and Lindquist, S.
(2012). Different 8-hydroxyquinolines protect models of TDP-43 protein,
a-synuclein, and polyglutamine proteotoxicity through distinct mechanisms.
J. Biol. Chem. 287, 4107–4120.
Tardito, S., Bassanetti, I., Bignardi, C., Elviri, L., Tegoni, M., Mucchino, C.,
Bussolati, O., Franchi-Gazzola, R., and Marchio`, L. (2011). Copper binding
agents acting as copper ionophores lead to caspase inhibition and paraptotic
cell death in human cancer cells. J. Am. Chem. Soc. 133, 6235–6242.
Tardito, S., Barilli, A., Bassanetti, I., Tegoni, M., Bussolati, O., Franchi-Gazzola,
R., Mucchino, C., and Marchio`, L. (2012). Copper-dependent cytotoxicity of
8-hydroxyquinoline derivatives correlates with their hydrophobicity and does
not require caspase activation. J. Med. Chem. 55, 10448–10459.
Valko, M., Morris, H., and Cronin, M.T.D. (2005). Metals, toxicity and oxidative
stress. Curr. Med. Chem. 12, 1161–1208.
Wagner, D., Maser, J., Lai, B., Cai, Z., Barry, C.E., 3rd, Ho¨ner Zu Bentrup, K.,
Russell, D.G., and Bermudez, L.E. (2005). Elemental analysis of
Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium
smegmatis-containing phagosomes indicates pathogen-induced microenvi-
ronments within the host cell’s endosomal system. J. Immunol. 174,
1491–1500.
Ward, S.K., Abomoelak, B., Hoye, E.A., Steinberg, H., and Talaat, A.M. (2010).
CtpV: a putative copper exporter required for full virulence of Mycobacterium
tuberculosis. Mol. Microbiol. 77, 1096–1110.
White, C., Lee, J., Kambe, T., Fritsche, K., and Petris, M.J. (2009). A role for the
ATP7A copper-transporting ATPase in macrophage bactericidal activity.
J. Biol. Chem. 284, 33949–33956.
Xiao, Z., Brose, J., Schimo, S., Ackland, S.M., La Fontaine, S., andWedd, A.G.
(2011). Unification of the copper(I) binding affinities of the metallo-chaperones
Atx1, Atox1, and related proteins: detection probes and affinity standards.
J. Biol. Chem. 286, 11047–11055.
Zhai, S., Yang, L., Cui, Q.C., Sun, Y., Dou, Q.P., and Yan, B. (2010). Tumor
cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline
and clioquinol requires their capabilities to bind copper and transport copper
into cells. J. Biol. Inorg. Chem. 15, 259–269.7–987, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 987
